Literature DB >> 30192113

ROLE OF P38 MAP-KINASE IN THE STRESS-INDUCED SENESCENCE PROGRESSION OF HUMAN ENDOMETRIUM-DERIVED MESENCHYMAL STEM CELLS.

A V Borodkina, A N Shatrova, N N Nikolsky, E B Burova.   

Abstract

Our recent findings clearly demonstrate that human endometrium-derived mesenchymal stem cells (hMESCs) respond to the sublethal oxidative stress by the premature senescence induction via ÀÒÌ/Chk2/p53/ p21/Rb pathway. Furthermore, based on the application of the SB203580 (SB) we suggested p38 MAP-kinase involvement in senescence progression. However, there are several disadvantages concerning this inhibitor: 1) using SB would not be suitable for in vivo experiments due to toxicity issue; 2) the poor kinase selectivity profile of SB complicates interpretation of the obtained data. Here, in order to confirm the implication of p38 in the H2O2-induced senescence of hMESCs, we applied another highly specific inhibitor of p38 — BIRB796 (BIRB). In presence of BIRB we revealed cell size decrease, reduction in the levels of reactive oxygen species, partial restoration of proliferation and increase in Rb phosphorylation levels in comparison to H2O2-treated hMESCs. Summarizing the obtained results we can postulate p38 implication in H2O2-induced senescence of hMESCs, and suggest p38 inhibition as a promising approach in prevention of premature senescence.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 30192113

Source DB:  PubMed          Journal:  Tsitologiia        ISSN: 0041-3771


  2 in total

1.  A Novel Technique for Accelerated Culture of Murine Mesenchymal Stem Cells that Allows for Sustained Multipotency.

Authors:  Courtney M Caroti; Hyunhee Ahn; Hector F Salazar; Giji Joseph; Sitara B Sankar; Nick J Willett; Levi B Wood; W Robert Taylor; Alicia N Lyle
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

Review 2.  An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling.

Authors:  Jiahuai Han; Jianfeng Wu; John Silke
Journal:  F1000Res       Date:  2020-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.